NANBIOSIS Unit 6 opens its doors to high school students, inspiring future scientists through hands-on experience in soft materials research.

Read the full article here: www.nanbiosis.es/nanbiosis-un...

#ICTSnews #NanbiosisExpertise #CEBS #CEBiomedS

NANBIOSIS contributes to a new research that reveals previously overlooked fecal metabolites linked to early MASLD under a high-fat diet, highlighting gut–liver metabolic interactions.

Full article: www.nanbiosis.es/new-animal-s...

#CEBS #CEBiomedS #NanbiosisExpertise #ICTSnews

Researchers from MSCA COFUND programmes and ARISTOS met in Madrid for a national networking event organised by FECYT and CIBER to strengthen collaboration and career development.

Read the full article here: www.nanbiosis.es/msca-cofund-...

#CEBS #CEBiomedS #ICTSnews #NanbiosisExpertise

Spain’s biotech leaders present a 10-point manifesto to strengthen strategic autonomy, calling for stronger investment, infrastructure and innovation policies

Full article: www.nanbiosis.es/spanish-biot...

#ICTSnews #NanbiosisExpertise #CEBS #CEBiomedS #Biotechnology #StrategicAutonomy

Remember her? Lucía Enríquez shares her current research stay at Kyoto University, advancing cystic fibrosis models with iPS cells and NANBIOSIS.
Full interview: www.nanbiosis.es/lucia-enriqu...
Watch in YT: www.youtube.com/watch?v=WItJ...

#NanbiosisInterviews #CEBS #CEBiomedS #ICTSnews

Our researchers from CSIC joined the 2nd CSIC Rare Diseases Network Meeting in Madrid to advance interdisciplinary rare disease research.

👉 Discover how NANBIOSIS can support your rare disease research: www.nanbiosis.es/nanbiosis-re...

#RareDiseases #NanbiosisExpertise #CEBS #CEBiomedS #ICTSnews

Last week we closed our first Open Competitive Call, and today we published the results:
www.nanbiosis.es/resolution-o...

Missed this call? The second (and last!) will open in June. If you’re in a rush you can still access our services via Access on Demand.

#CEBS #ICTSnews #CEBiomedS

New research shows how a tumor metabolite (2HG) can make aggressive glioma cells less invasive and more sensitive to treatment, with the support of NANBIOSIS infrastructure.
More👉 www.nanbiosis.es/how-a-tumor-...

#CEBS #CEBiomedS #ICTSnews #NanbiosisExpertise #WorldCancerDay #Glioma #Glioblastoma

NANBIOSIS at #S4i2026!
We contributed to a key round table discussing science–industry collaboration together with leaders from the field.

🔗 Read more: www.nanbiosis.es/nanbiosis-st...

#ICTSnews #CEBS #NanbiosisExpertise #CEBiomedS #ScienceForIndustry #TechnologyTransfer #Innovation #S4i

NANBIOSIS Unit 18 contributes to two studies advancing CXCR4-targeted nanoconjugates for acute myeloid leukemia, highlighted on #WorldCancerDay.

Read more: www.nanbiosis.es/nanbiosis-ad...

#ICTSnews #CEBiomedS #NanbiosisExpertise #CEBS #CancerResearch #Nanomedicine

NANBIOSIS Unit 2 (CAbS) participates in the III SENTIATECH Meeting, showcasing nanobiotechnology and diagnostics for health risk monitoring.

More information: www.nanbiosis.es/nanbiosis-un...

#CEBS #ICTSnews #NanbiosisExpertise #CEBiomedS

🚨 Last days to apply!
The #NANBIOSIS Competitive Open Call closes January 31.
Do not miss your chance to access advanced R&D platforms. Apply now!
More information: www.nanbiosis.es/ready-your-p...
#CEBS #CEBiomedS #NanbiosisExpertise #ICTSnews

Our latest video shows the Preclinical Histology workflow of NANBIOSIS Unit 20 at VHIR, part of an integrated platform for preclinical validation and imaging.

www.youtube.com/shorts/PwYuC...

#CEBS #NanbiosisExpertise #CEBiomedS #ICTSnews

Researchers & companies: this is your opportunity.
Use #NANBIOSIS services to strengthen your innovation pipeline.
📆 Until January 31 (this week!).
More information: www.nanbiosis.es/ready-your-p...
#CEBS #CEBiomedS #NanbiosisExpertise #ICTSnews

📬 Our NANBIOSIS Newsletter is here!
Get curated updates: no spam, just the highlights.
🎉 Celebrating 10 years as an ICTS with key news from 2025 and what’s coming in 2026.

👉 Subscribe now and stay connected! More info: www.nanbiosis.es/nanbiosis-la...

#CEBS #CEBiomedS #ICTSnews

Advance your biomedical or nanotech research.
Apply to the #NANBIOSIS Open Call and access expert platforms.
⏰ Closes Jan 31.
More information: www.nanbiosis.es/ready-your-p...
#CEBS #CEBiomedS #NanbiosisExpertise #ICTSnews

Innovation needs the right partners.
Join the #NANBIOSIS ecosystem through the Competitive Open Call.
🕒 Deadline: January 31.
More information: www.nanbiosis.es/ready-your-p...
#CEBS #CEBiomedS #NanbiosisExpertise #ICTSnews

Looking to accelerate your project?
Become a #NANBIOSIS user and access unique R&D infrastructure.
📅 Apply by Jan 31.
More information: www.nanbiosis.es/ready-your-p...
#CEBS #CEBiomedS #NanbiosisExpertise #ICTSnews

Take your research further.
Access high-level services via the #NANBIOSIS Competitive Open Call.
⏳ Open until January 31.
More information: www.nanbiosis.es/ready-your-p...
#CEBS #CEBiomedS #NanbiosisExpertise #ICTSnews

Don’t miss your chance to innovate.
Researchers & companies: enter the NANBIOSIS ecosystem now.
📅 Apply before January 31.
More info: www.nanbiosis.es/ready-your-p...

#ICTSnews #CEBiomedS #CEBS #NanbiosisExpertise #Nanomedicine #Innovation

NANBIOSIS Newsletter is here!
You can read the first number here: mailchi.mp/1d6b86177905...
Subscribe to recevie future chapters every 2 months: nanbiosis.us4.list-manage.com/subscribe?u=...

#CEBS #CEBiomedS #ICTSnews #NanbiosisExpertise

Innovation starts with the right tools.
Access NANBIOSIS platforms and accelerate your project.
⏰ Competitive Open Call open until Jan 31.
More info: www.nanbiosis.es/ready-your-p...

#ICTSnews #CEBiomedS #CEBS #NanbiosisExpertise #Nanomedicine #Innovation

New advanced solution published! #ICTSnews
🫁 Advanced aerosol formulations for pulmonary drug delivery: End-to-end development and characterization for precise and effective lung therapy.

More info: www.nanbiosis.es/aerosols-for...

#CEBS #CEBiomedS #NanbiosisExpertise #Nanomedicine #DrugDelivery

Need advanced biomedical or nanotech services?
Become a #NANBIOSIS user today and stay competitive.
🚀 Deadline: January 31.
More info: www.nanbiosis.es/ready-your-p...

#ICTSnews #CEBiomedS #CEBS #NanbiosisExpertise #Nanomedicine #Innovation

From idea to solution: faster.
Join NANBIOSIS and boost your R&D with expert-supported services.
🗓️ Open Call closes Jan 31.More info: www.nanbiosis.es/ready-your-p...

#ICTSnews #CEBiomedS #CEBS #NanbiosisExpertise #Nanomedicine #Innovation

Mark the date! Our Open call will kick off on Jan 1st 2026.
More info: www.nanbiosis.es/ready-your-p...

#CEBS #ICTSnews #NanbiosisExpertise #CEBiomedS #Biomedicine #Bioengineering #Nanomedicine #CuttingEdge

Turn your research into impact.
Access cutting-edge infrastructure through the NANBIOSIS Competitive Open Call.
⏳ Apply by January 31.
More info: www.nanbiosis.es/ready-your-p...

#ICTSnews #CEBiomedS #CEBS #NanbiosisExpertise #Nanomedicine #Innovation

Mark the date! Our Open call will kick off on Jan 1st 2026.
More info: www.nanbiosis.es/ready-your-p...

#CEBS #ICTSnews #NanbiosisExpertise #CEBiomedS #Biomedicine #Bioengineering #Nanomedicine #CuttingEdge

We’ve just launched our official NANBIOSIS newsletter 🎉
Stay up to date with the latest news, success stories, and opportunities from #Biomaterials, nanomedicine, and #bioengineering.

Subscribe now 👉 mailchi.mp/1d6b86177905...

#CEBS #CEBiomedS #ICTSnews #NanbiosisExpertise #Nanomedicine

New article! A multimodal CMR/PET study uncovers how infarct size, cardiac function and metabolism evolve in mouse models of myocardial infarction.
Our Unit 26 provided key technical expertise and imaging.
Read more: www.nanbiosis.es/nanbiosis-u2...

#CEBS #CEBiomedS #ICTSnews #NanbiosisExpertise